﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH</title><copyright>Copyright © 2013 Knight Sac Media.  All rights reserved.</copyright><link>http://www.siliconinvestor.com/subject.aspx?subjectid=14049</link><description>
AASTROM is developing proprietary process technologies and devices for a range of cell therapy applications, including stem cell therapies and gene therapies. _______________________________________  what do ya'll think about this biotech company.  it recently ipo'd at $7.  it's in the low $6s.  th...</description><image><url>http://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH</title><link>http://www.siliconinvestor.com/subject.aspx?subjectid=14049</link><width>380</width><height>132</height></image><ttl>10</ttl><item><title>[Glenn Petersen] Aastrom cutting workforce, ending clinical trial   Aastrom Biosciences cutting w...</title><author>Glenn Petersen</author><description>Aastrom cutting workforce, ending clinical trial   Aastrom Biosciences cutting workforce by about 50 percent., ending clinical drug trial  Associated Press  March 27, 2013   ANN ARBOR, Mich. (AP) -- Aastrom Biosciences Inc. is cutting its workforce by about 50 percent and ending a clinical drug trial.   Shares of the c...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=28802006</link><pubDate>3/27/2013 11:37:07 AM</pubDate></item></channel></rss>